Senior insider sale
BIOCRYST PHARMACEUTICALS INC — senior position signals high conviction
$504.6K
49.93K shares
What this filing means
HEGGIE THERESA plans to sell 49.93K shares of BIOCRYST PHARMACEUTICALS INC valued at approximately $504.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/20/2026ACC: 0001959173-26-002529
Director
Since Dec 2018
49.93K
Shares to sell
$504.6K
Approx. market value
49.93K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Option Granted 06/12/2024
Cash
3/20/2026
49.93KTotal acquired49.93K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/20/2026 | Option Granted 06/12/2024 Cash | 49.93K | — |
| Total | 49.93K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
49.93K
Market value
$504.6K
3/20/2026
Total
Units
49.93K
Value
$504.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/20/2026 | 49.93K | $504.6K | NASDAQ | Planned |
| Total | 49.93K | $504.6K | ||